Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Myles

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Molecular Endocrinology (Baltimore, Md.)|August 26, 1998
Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteinsC Logie, M Nichols, K Myles, et al.
Biotechniques|November 26, 1999
Infecting larval arthropods with a chimeric, double subgenomic Sindbis virus vector to express genes of interestS Higgs, C T Oray, K Myles, et al.
Recent Progress in Hormone Research|January 1, 1997
Mineralocorticoid receptors, salt, and hypertensionJ W Funder, Z Krozowski, K Myles, et al.
Lancet (London, England)|October 25, 1975
Down syndrome and thyroid function in adultsR G Baxter, R G Larkins, F I Martin, et al.
Endocrinology|March 17, 2001
The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone actionA Bhargava, M J Fullerton, K Myles, et al.
Journal of the American College of Surgeons|August 26, 2006
Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology GroupY Nancy You, Lisa Jacobs, Elizabeth D Martinez, et al.
Molecular and Cellular Endocrinology|February 27, 2001
GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistantT J Cole, K Myles, J F Purton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2000
The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liverE G Schuetz, W Schmid, G Schutz, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
Circulation|July 28, 2010
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary interventionMauricio G Cohen, Drew A Purdy, Joseph S Rossi, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Molecular Endocrinology (Baltimore, Md.)|August 26, 1998
Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteinsC Logie, M Nichols, K Myles, et al.
Biotechniques|November 26, 1999
Infecting larval arthropods with a chimeric, double subgenomic Sindbis virus vector to express genes of interestS Higgs, C T Oray, K Myles, et al.
Recent Progress in Hormone Research|January 1, 1997
Mineralocorticoid receptors, salt, and hypertensionJ W Funder, Z Krozowski, K Myles, et al.
Lancet (London, England)|October 25, 1975
Down syndrome and thyroid function in adultsR G Baxter, R G Larkins, F I Martin, et al.
Endocrinology|March 17, 2001
The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone actionA Bhargava, M J Fullerton, K Myles, et al.
Journal of the American College of Surgeons|August 26, 2006
Improved surgeon performance in clinical trials: an analysis of quality assurance audits from the American College of Surgeons Oncology GroupY Nancy You, Lisa Jacobs, Elizabeth D Martinez, et al.
Molecular and Cellular Endocrinology|February 27, 2001
GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistantT J Cole, K Myles, J F Purton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 19, 2000
The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liverE G Schuetz, W Schmid, G Schutz, et al.
Circulation|November 15, 2006
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activityChristopher K Dyke, Steven R Steinhubl, Neal S Kleiman, et al.
Circulation|July 28, 2010
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary interventionMauricio G Cohen, Drew A Purdy, Joseph S Rossi, et al.
Pageof 3